Top Markets
#1 Helium Helium +54.86%
#2 GEKKO GEKKO +52.86%
#3 ADO Protocol ADO Protocol +38.95%
#4 StonkBroker StonkBroker +36.73%
#5 Pons Pons +36.17%
#6 TENDIES TENDIES +35.28%
#7 Prom Prom +30.65%
#8 Collector Crypt Collector Crypt +29.96%
#9 o1.exchange o1.exchange +21.00%
#10 Cysic Cysic +20.09%
Coin of the day
Helium Helium
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Chengdu Kanghua Biological Products Co., Ltd. Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd.

300841
Rang in aandelen #9575
Chengdu Kanghua Biological Products Co., Ltd. engages in the research,... Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
Aandeelprijs
$7.60
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$987.13M
Verandering (1 dag)
-5.04%
Verandering (1 jaar)
-28.09%
Land
CN
Handel Chengdu Kanghua Biological Products Co., Ltd. (300841)

Categorie

Healthcare
Koersgeschiedenis voor Chengdu Kanghua Biological Products Co., Ltd. (300841)
Hoogste slotkoers: $7.53 op 2026-08-01

Laagste slotkoers: $9.58 op 2020-06-01
Koersgeschiedenis van Chengdu Kanghua Biological Products Co., Ltd. van 2020 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -16.00%
2025 37.71%
2024 -22.82%
2023 -19.13%
2022 -29.54%
2021 -43.13%
2020 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH